STOMACH

Effect of scheduled second therapeutic endoscopy on peptic ulcer rebleeding: a prospective randomised trial

P W Y Chiu, C Y W Lam, S W Lee, K H Kwong, S H Lam, D T Y Lee, S P Y Kwok

Department of Surgery and Endoscopy Centre, United Christian Hospital, Kwun Tong, Hong Kong SAR, China

Correspondence to:
Correspondence to:
Dr P W Y Chiu, Surgery, United Christian Hospital, 130 Hip Woo St, Kwun Tong, Hong Kong SAR, China;
pchiu{at}hkstar.com

Aim: Recurrent bleeding after initial haemostasis is an important factor that directly relates to the outcome in the management of peptic ulcer bleeding. Conflicting reports have been published concerning the effectiveness of scheduled second therapeutic endoscopy on ulcer rebleeding. We investigate the use of scheduled second endoscopy with appropriate therapy on peptic ulcer rebleeding.

Methods: From August 1999 to January 2001, we prospectively randomised patients who had endoscopically confirmed bleeding peptic ulcer with stigmata of acute bleeding, visible vessel, or adherent clot into two groups. Endoscopic therapy was standardised to initial epinephrine injection and subsequent heater probe application. The study group (n = 100) received scheduled second endoscopy 16–24 hours after initial haemostasis, and further therapy was applied if endoscopic stigmata persisted, as above. The control group (n = 94) were observed closely. Those patients that developed rebleeding in either group underwent operation if further endoscopic therapy failed. Outcome measures included ulcer rebleeding, transfusion, duration of stay, and mortality.

Results: After initial endoscopic haemostasis, 194 eligible patients were randomised into two groups. Thirteen patients in the control group developed recurrent bleeding within 30 days while five patients in the study group sustained recurrent bleeding (p = 0.0314) (relative risks 0.33, 95% confidence interval 0.1–0.96). The number of patients that required surgery for recurrent bleeding was six in the control group and one in the study group (p = 0.05). There was no difference in duration of hospital stay, transfusion, or mortality between the two groups.

Conclusions: A scheduled repeat endoscopy with appropriate therapy 16–24 hours after initial endoscopic haemostasis reduces the number of cases of recurrent bleeding.

Keywords: peptic ulcer bleeding; scheduled second endoscopy; therapeutic endoscopy; ulcer rebleeding

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Article

Digest

Robin Spiller
Gut 2003 52: 1391. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

• Spiller, R C (2004). Progress report. Gut 53: 317-317 [Full Text]  
• (2004). A Second Look at Second-Look Endoscopy for Bleeding Peptic Ulcers. JWatch Gastroenterology 2004: 3-3 [Full Text]  
• (2004). ADDITIONAL ARTICLES ABSTRACTED IN ACP JOURNAL CLUB. Evid. Based Med. 9: 3-3 [Full Text]  

eLetters:

Read all eLetters

Moving forwards not sideways

Richard G Fiddian-Green

Gut Online, 25 Nov 2003 [Full text]

Diagnotic endoscopy: does it help?

Richard G Fiddian-Green

Gut Online, 24 Nov 2003 [Full text]

Preventing rebleeding from PUD

Richard G Fiddian-Green

Gut Online, 11 Dec 2003 [Full text]

Author's reply

Philip WY Chiu

Gut Online, 17 Dec 2003 [Full text]

Not enough PPI infusion

Burçak Kayhan, et al.

Gut Online, 27 Jan 2005 [Full text]

Cost-effectiveness of adding PPI to scheduled second endoscopy

Philip WY Chiu

Gut Online, 1 Feb 2005 [Full text]